Vistusertib (AZD2014)

  • Trial Availability: USA
  • Tumor Target: Recurrent Meningioma
  • Treatment by: Pill - Oral
  • Inhibits: mammalian target of rapamycin (mTOR)
  • Recruiting Trial: NCT02523014
  • Recruiting Trial: NCT02831257
  • Not Open: NCT03071874

Crizotinib () Vistusertib (AZD2014)
GSK2256098 PI3K/Akt/mTOR signaling pathway
Synonym: AZD2014; AZD-2014; AZD 2014; Vistusertib
IUPAC/Chemical Name: 3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide
Pill
Solubility: Soluble in DMSO, not in water. Dimethyl Sulfoxide (DMSO) is an organosulfur compound with the formula (CH3)2SO.
http://www.medkoo.com/products/4591
What is NF2? | About Us | Treatment Options | Sitemap

Disclaimer: Neurofibromatosis Type 2 - Information and Services, www.nf2is.org, is not run by medical experts, affiliated with any healthcare organization or any other company. No assurance can be made to the accuracy or completeness of the information provided here, the accuracy of other sites to which this site links, or of sites that link to this site. - Read More

Copyright © 2008 - 2017